Covidien PLC

Most Recent

  • Healthcare

    Farallon Capital adds a new position in Covidien

    Ireland-based Covidien is a global healthcare leader that offers innovative medical technology solutions and patient care products to providers.

    By Patricia Garner
  • Consumer

    Farallon Capital exits its position in Time Warner Cable

    In February, Comcast agreed to buy Time Warner Cable for ~$45.2 billion. This deal will create the largest cable provider in the U.S.

    By Patricia Garner
  • Consumer

    Farallon Capital raises its position in Safeway

    On March 6, 2014, grocery store operators Safeway and Albertsons announced a merger agreement valued at approximately $9 billion.

    By Patricia Garner
  • uploads///TWC CMCSA
    Technology & Communications

    Must-know: Is the Time Warner Cable–Comcast deal a “do?”

    Arbs generally avoid utility deals—and for good reason. Typically, the companies have an aggressive expected timeline and these deals don’t close on time.

    By Brent Nyitray, CFA, MBA
  • Consumer

    Farallon Capital establishes a new position in Hillshire Brands

    Hillshire reported fiscal 4Q14 net sales of $1.1 billion, up 10.7% in comparison to the corresponding period last year.

    By Patricia Garner
  • uploads///Graph
    Company & Industry Overviews

    Novartis Aims to Turn Around Its Surgical Business in 2017

    In 2016, the surgical business of Alcon, Novartis’s (NVS) Consumables segment, witnessed a solid demand trend.

    By Margaret Patrick
  • uploads///GILD
    Fund Managers

    Renaissance Technologies starts new position in Gilead Sciences

    In February 2015, Gilead announced its 4Q14 results and reported revenues of $7.3 billion, a significant increase of 137% compared to $3.1 billion for 4Q13.

    By Adam Rogers
  • uploads///covidien
    Fund Managers

    Chilton Investment Company raises its stake in Covidien plc

    Chilton Investment added to its position in Covidien plc (COV) in 4Q14. The position accounts for 3.22% of the fund’s 4Q14 portfolio, up from 0.49% in 3Q14.

    By Adam Rogers
  • uploads///COV
    Fund Managers

    Farallon Capital ups stake in Covidien

    Farallon Capital Management increased its position in Covidien plc (COV) during the third quarter. The stock accounted for 5.06% of the fund’s total 3Q14 portfolio.

    By Diana Key
  • uploads///TWC CMCSA
    Technology & Communications

    Strategic rationale for the Time Warner Cable–Comcast deal

    On February 12, 2014, Time Warner Cable (TWC) and Comcast (CMCSA) agreed to merge. The two companies provide cable TV and broadband access separate geographic areas.

    By Brent Nyitray, CFA, MBA
  • uploads///TEG WEC historical
    Energy & Utilities

    Why consider possible Integrys–Wisconsin Energy merger scenarios?

    In the risk arbitrage world, a 2% spread means a deal without much “hair” on it. The market is assigning a high probability of closing.

    By Brent Nyitray, CFA, MBA
  • uploads///TEG WEC arb spread
    Energy & Utilities

    Should you get involved in the Integrys–Wisconsin Energy deal?

    In merger arbitrage, you’ll generally buy the acquired company’s stock and sell short the acquiring company’s stock. So how will this play out when you look at the Integrys-Wisconsin deal?

    By Brent Nyitray, CFA, MBA
  • uploads///COV MDT Spread
    Technology & Communications

    Spread analysis: Does the Covidien-Medtronic merger make sense?

    To perform merger arbitrage, the investor will generally buy the stock of the company being acquired and sell short the stock of the acquiring company.

    By Brent Nyitray, CFA, MBA
  • uploads///COV MDT terms
    Technology & Communications

    Key overview: Merger arbitrage and the Covidien-Medtronic deal

    The Covidien-Medtronic deal is a scheme of arrangement, which is an English-style merger where a court has to approve the transaction once the votes are in.

    By Brent Nyitray, CFA, MBA
  • uploads///MDT COV slide
    Technology & Communications

    Understanding the rationale for the Covidien-Medtronic transaction

    On June 15, 2014, Medtronic (MDT) and Covidien (COV) reached an agreement to merge via a scheme of arrangement. The two companies more or less offer complementary goods.

    By Brent Nyitray, CFA, MBA
  • uploads///Covidien
    Technology & Communications

    The Covidien-Medtronic merger: Key background on Covidien

    Covidien PLC (COV) describes itself as “a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings.”

    By Brent Nyitray, CFA, MBA
  • Basic Materials

    A guide to Iridian Asset Management’s investment strategy

    As of September 30, 2013, Iridian’s assets under management totaled $10.1 billion in U.S. mid-cap and small-cap equity strategies.

    By Samantha Nielson
  • uploads///blood pressure
    Healthcare

    Is renal denervation a new medical device stocks cash cow?

    No US companies have approved renal denervation devices in the US market, but they’re in the process of testing and selling these devices.

    By Amritpal Khalsa
  • Healthcare

    Are Covidien’s layoffs good for the medical device industry?

    Covidien (COV) announced that it will lay off a significant amount of employees as part of global restructuring efforts. The initiative aims to save the company up to $300 million a year by fiscal 2018.

    By Amritpal Khalsa
  • uploads///israel
    Healthcare

    Why Israel is poised to soon lead medical device industry growth

    Espicom Business Intelligence forecasts the Israeli market to be valued at $1.096 billion in 2016—a 20% increase over five years. The country looks to the medical device industry for a significant amount of growth.

    By Amritpal Khalsa
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.